SuperworthLexaria Bioscience shares outstanding LEXX
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to May 31, 2026
- 1.7M
- On a year earlier
- +35.6%
- more shares
Lexaria Bioscience had 1.7M diluted shares outstanding on average in Q3 FY26, the quarter to May 31, 2026.
That is 35.6% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 1.3M | +25% |
| FY2024 | 1M | +94% |
| FY2023 | 539.4K | +36% |
| FY2022 | 396.7K | +11% |
| FY2021 | 359K | +80% |
| FY2020 | 199.7K | +14% |
| FY2019 | 174.7K | +8% |
| FY2018 | 162.4K | +9% |
| FY2017 | 149K | +44% |
| FY2016 | 103.6K | +7% |
| FY2015 | 97.1K | +36% |
| FY2014 | 71.2K | −27% |
| FY2014 | 97.7K | +168% |
| FY2013 | 36.5K | +0% |
| FY2012 | 36.5K | +1% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q3 FY26 | 1.7M | +36% | |
| Q2 FY26 | 1.6M | +40% | |
| Q1 FY26 | 1.4M | +28% | |
| Q4 FY25 | 1.3M | +25% | |
| Q3 FY25 | 1.2M | +32% | |
| Q2 FY25 | 1.2M | +63% | |
| Q1 FY25 | 1.1M | +84% | |
| Q4 FY24 | 1M | +94% | |
| Q3 FY24 | 923.7K | +115% | |
| Q2 FY24 | 717.7K | +81% | |
| Q1 FY24 | 603.4K | +52% | |
| Q4 FY23 | 539.4K | +36% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Lexaria Bioscience
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.